Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Accel. buyback
Quarterly results
Auditor change
|
|
AbbVie Inc. (ABBV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 50 options to buy
@ $149.06, valued at
$7.5k
|
|
| 10/03/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 259 options to buy
@ $149.06, valued at
$38.6k
|
|
| 09/27/2023 |
4
| GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 42,000 shares
@ $0 |
|
| 08/02/2023 |
4
| GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 18,500 shares
@ $149.15, valued at
$2.8M
Sold 60,000 shares
@ $148.58, valued at
$8.9M
|
|
| 07/05/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 287 options to buy
@ $134.73, valued at
$38.7k
|
|
| 07/05/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 55 options to buy
@ $134.73, valued at
$7.4k
|
|
| 05/12/2023 |
4
| Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 2,876 shares
@ $146.42, valued at
$421.1k
|
|
| 05/09/2023 |
4
| WADDELL FREDERICK H (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| TILTON GLENN F (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| Roberts Rebecca B (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| MEYER MELODY B (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| Hart Brett J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| AUSTIN ROXANNE S (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| BURNSIDE WILLIAM H.L. (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/02/2023 |
4
| TILTON GLENN F (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Exercised 2,230 options to buy
@ $151.12, valued at
$337k
|
|
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Sorg Elaine K. (SVP, US COMMERCIAL OPERATIONS) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 15,002 shares
@ $160.03, valued at
$2.4M
Exercised 15,002 options to buy
@ $93.5, valued at
$1.4M
|
|
| 04/05/2023 |
4
| Siatis Perry C (EVP, GC AND SECRETARY) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 3,520 shares
@ $160, valued at
$563.2k
Exercised 3,520 options to buy
@ $105.92, valued at
$372.8k
|
|
| 04/04/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 47 options to buy
@ $159.37, valued at
$7.5k
|
|
| 04/04/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 243 options to buy
@ $159.37, valued at
$38.7k
|
|
| 03/15/2023 |
4
| Stewart Jeffrey Ryan (EVP, CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 21,810 shares
@ $152.3, valued at
$3.3M
Sold 31,315 shares
@ $152.27, valued at
$4.8M
Exercised 21,810 options to buy
@ $54.86, valued at
$1.2M
|
|
| 03/07/2023 |
4
| GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 2,550 shares
@ $0 |
|
| 03/07/2023 |
4
| Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 449 shares
@ $156.06, valued at
$70.1k
|
|
| 03/02/2023 |
4
| Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 5,762 shares
@ $154.28, valued at
$889k
Paid exercise price by delivering 810 shares
@ $155.27, valued at
$125.8k
|
|
| 03/02/2023 |
4
| Sorg Elaine K. (SVP, US COMMERCIAL OPERATIONS) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 19,850 shares
@ $154.28, valued at
$3.1M
Sold 15,003 shares
@ $155, valued at
$2.3M
Exercised 15,003 options to buy
@ $93.5, valued at
$1.4M
|
|
| 03/02/2023 |
4
| Siatis Perry C (EVP, GC AND SECRETARY) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 9,656 shares
@ $154.28, valued at
$1.5M
Sold 11,330 shares
@ $153.06, valued at
$1.7M
Sold 805 shares
@ $153.38, valued at
$123.5k
|
|
| 03/02/2023 |
4
| Reents Scott T (EVP, CFO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 12,683 shares
@ $154.28, valued at
$2M
Sold 15,092 shares
@ $153.06, valued at
$2.3M
Sold 850 shares
@ $153.38, valued at
$130.4k
|
|
| 03/02/2023 |
4
| Durkin Brian L (VP, CONTROLLER) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 11,182 shares
@ $154.28, valued at
$1.7M
|
|
| 03/02/2023 |
4
| Stewart Jeffrey Ryan (EVP, COMMERCIAL OPERATIONS) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 24,910 shares
@ $154.28, valued at
$3.8M
|
|
| 03/02/2023 |
4
| SALEKI-GERHARDT AZITA (EVP, OPERATIONS) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 33,359 shares
@ $154.28, valued at
$5.1M
Sold 26,990 shares
@ $155, valued at
$4.2M
Sold 9,220 shares
@ $153.05, valued at
$1.4M
Sold 780 shares
@ $153.39, valued at
$119.6k
Exercised 26,990 options to buy
@ $51.42, valued at
$1.4M
|
|
|
|
|